| |
| |
|
| Insider
Information: |
Graham Ginger L |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
141,600 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$33,411 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
141,600 |
|
|
| Total
Value |
$33,411 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2009-03-18 |
139,450 |
2005-01-04 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2011-04-01 |
0 |
2019-11-08 |
0 |
Premium* |
|
|
Walgreens Boots Alliance, Inc. |
WBA |
Director |
2017-10-26 |
2,150 |
2017-10-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GHDX |
Genomic Health Inc |
Director |
– • – |
2016-10-01 |
4 |
A |
$28.92 |
$9,977 |
I/I |
345 |
8,172 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-01-01 |
4 |
A |
$29.39 |
$9,993 |
I/I |
340 |
8,512 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-04-01 |
4 |
A |
$31.49 |
$9,982 |
I/I |
317 |
8,829 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-07-01 |
4 |
A |
$32.55 |
$9,993 |
I/I |
307 |
9,136 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2017-10-01 |
4 |
A |
$32.09 |
$9,980 |
I/I |
311 |
9,447 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2018-01-01 |
4 |
A |
$34.20 |
$9,986 |
I/I |
292 |
9,739 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2018-04-01 |
4 |
A |
$31.29 |
$9,982 |
I/I |
319 |
10,058 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2018-07-01 |
4 |
A |
$50.40 |
$9,979 |
I/I |
198 |
10,256 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2018-10-01 |
4 |
A |
$70.18 |
$9,966 |
I/I |
142 |
26,898 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-01-01 |
4 |
A |
$64.41 |
$9,984 |
I/I |
155 |
51,803 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-04-01 |
4 |
A |
$66.84 |
$9,959 |
I/I |
149 |
51,952 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-06-14 |
4 |
A |
$0.00 |
$0 |
I/I |
955 |
52,907 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-07-01 |
4 |
A |
$58.86 |
$12,478 |
I/I |
212 |
53,119 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-10-01 |
4 |
A |
$67.28 |
$12,447 |
I/I |
185 |
53,304 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-08-06 |
4 |
AS |
$49.50 |
$495,013 |
D/D |
(10,000) |
147,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-08-07 |
4 |
AS |
$50.51 |
$505,101 |
D/D |
(10,000) |
147,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Executive Advisor |
• – – |
2007-08-08 |
4 |
AS |
$51.11 |
$1,183,598 |
D/D |
(23,000) |
147,523 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
• – – |
2005-05-06 |
4 |
B |
$16.65 |
$199,800 |
D/D |
12,000 |
118,535 |
2.74 |
- |
|
| WBA |
Walgreens Boots Alliance,... |
Director |
– • – |
2017-10-26 |
4 |
B |
$69.86 |
$150,199 |
D/D |
2,150 |
2,150 |
2.39 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-11-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(53,304) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2009-03-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,565 |
139,450 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
• – – |
2005-01-04 |
4 |
OE |
$7.13 |
$213,750 |
D/D |
30,000 |
105,600 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-05 |
4 |
OE |
$12.25 |
$122,500 |
D/D |
10,000 |
129,706 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President and Chief Executive |
• – – |
2006-06-09 |
4 |
OE |
$16.54 |
$249,981 |
D/D |
10,869 |
141,496 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Executive Officer |
• – – |
2006-12-05 |
4 |
OE |
$23.00 |
$49,979 |
D/D |
2,173 |
144,082 |
0 |
- |
|
58 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
